PharmaLectures.com

Courses › Pharma training by role › Owner, CEO and board: your first month in pharma, starting from zero

Owner, CEO and board: your first month in pharma, starting from zero

Your board decides on compliance questions in the meeting, not after a call to counsel.

  • 8 audio modulesthree lengths each
  • 1 h 20 min to 6 h 40 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Owner, CEO and boardwho it is written for

Why this training matters

An inspector opens your first Quality Manual and finds gaps against Good Manufacturing Practice. Your team spends the next months rewriting procedures instead of preparing the filing. A competitor files its marketing authorization application while you are still fixing paragraphs.

What changes after this course

Your leadership team builds operations to Good Manufacturing Practice from the first document. Board members answer investor and inspector questions without a call to counsel. You hold a certificate for every learner and a training record for each person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

A vendor presents at your next board meeting, and someone asks how Chapter 7 of EudraLex Volume 4 treats outsourced activities. You have the answer, because your board has already heard what a contract giver must check and write down. Site location decisions move faster once the regulatory limits are clear.

Your executive team drafts quality documents that follow International Council for Harmonisation guideline Q10 on the pharmaceutical quality system. When an investor asks about your Investigational New Drug application under Title 21 of the Code of Federal Regulations, Part 312, your chief executive officer names the phases and data packages. Your corporate structure already supports clinical trial applications, so no legal reorganization interrupts the filing.

Budgets stop being generic. Your finance lead builds a model that carries clinical trial costs and compliance overhead side by side. Your hiring managers know which qualifications to check when they interview a first Qualified Person under Directive 2001/83/EC. New executives start with a clear view of their own responsibility for product safety.

On the first walk through, your team hands the inspector training records and a Site Master File that match the floor. Early deviations get answered in the right terms, with the record in hand. Nobody scrambles for a document, because each one sits where an inspector expects to find it.

Who needs this training

  • Chief Executive Officer of a new pharmaceutical company

    They sit across from investors and defend the date of the first Investigational New Drug application, then answer the follow-up question about the quality system without turning to a colleague.

  • Board member overseeing a biotech venture

    They approve the first budget and must see that early Good Manufacturing Practice compliance is funded before the vote, not after the first inspection letter arrives.

  • Founder of a pharmaceutical company

    They face the blank page of a Quality Manual and need to write the policies that set how the whole company works, in a form an inspector accepts.

  • Early-stage healthcare investor

    They read pitch decks and need to spot the hole in a clinical trial timeline, such as a missing sponsor or legal representative, before the check is written.

Roles: Owner, CEO and board

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: any jurisdiction

Courses are in English. Other languages on request.

After this course your people can

  1. Draft a corporate structure plan that supports your first clinical trial application.
  2. Write a Quality Manual that follows the pharmaceutical quality system described in Chapter 1 of EudraLex Volume 4.
  3. Build a six-month budget that shows compliance overhead as its own visible line.
  4. Map the patent filings that protect each early drug candidate before results are published.
  5. Check a Qualified Person's credentials against Article 49 of Directive 2001/83/EC before offering the contract.
  6. Assemble the Site Master File and key procedures an inspector asks for first.
  7. Explain to an inspector, in plain terms, how an early deviation was found and closed.

What the company gets

  • Your company avoids restructuring its legal entity just before a major filing, so the submission date holds.
  • Your quality management system reaches its first external review with documents that match how the site actually runs.
  • Investors receive timelines for regulatory submissions that your leadership can explain line by line.
  • Personnel files are built correctly from the first hire, so the training record is complete when the inspector asks.
  • Inspectors who walk in find records where they expect them, and your team answers without a search.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 8 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 20 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard3 h 20 min25 min a module, for regulatory, quality and business-development staff
Expanded6 h 40 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing1 h 20 min

Course outline: 8 modules

8 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Read the pharmaceutical market and place your business where it can win

    • How to tell whether the European Medicines Agency or the Food and Drug Administration sets your pace.
    • The contract manufacturing question that decides whether you build capacity or rent it.
    • What to check about a supplier in your first month, before a delay shows up in the plan.
  2. 2Choose the legal and corporate structure that will carry your first filings

    • Why the sponsor or legal representative must be settled before you file a clinical trial application.
    • What your directors owe the company, and how that shapes every investor report you sign off.
    • How to word your bylaws so investor due diligence finds answers instead of questions.
  3. 3Meet your first regulatory obligations in the order authorities expect

    • What to do when your first Food and Drug Administration filing depends on a site not yet inspected.
    • The Good Manufacturing Practice rules in Chapter 3 of EudraLex Volume 4 that decide your floor plan.
    • How to build a submission timeline that shows each dependency before a reviewer finds it.
  4. 4Draft the quality management system documents an inspector opens first

    • The topics a first Quality Manual needs so that it holds up when the inspector opens it.
    • How to write standard operating procedures that operators follow instead of working around.
    • Why a borrowed quality system template fails the day an inspector compares it with your site.
  5. 5Secure funding and set the financial oversight your investors ask for

    • How to present a six-month budget that early-stage investors can check line by line.
    • The financial reports pharmaceutical investors ask for first, and how to produce them on request.
    • When to commit funds to clinical trials and when to hold them back for compliance.
  6. 6Plan a product pipeline and development strategy you can defend to the board

    • How to sequence clinical trial phases so each one earns the next regulatory step.
    • The patent filings that protect an early drug candidate before a rival publishes first.
    • What to do when early research data forces a pivot and the board wants a straight answer.
  7. 7Hire and onboard the key people regulators require, in the right order

    • How to check a Qualified Person against Article 49 of Directive 2001/83/EC before you sign the contract.
    • The training records an inspector asks for on the first walk through, ready in the right folder.
    • Why hiring quality staff late puts your manufacturing authorization at risk.
  8. 8Pass your first regulatory inspection without major findings

    • The documents to put on the table before the inspector sits down.
    • How to answer questions about early deviations without implying the whole system has failed.
    • What to do when an inspector asks for a record that does not exist yet.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

8 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 20 min in the briefing length and 6 h 40 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Owner, CEO and board. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 72 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team